Holen Sie sich die Stockscreener-App
116.79
2.92%
3.31
Handel nachbörslich:
116.88
0.09
+0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$113.48
Offen:
$114.25
24-Stunden-Volumen:
8.36M
Relative Volume:
1.78
Marktkapitalisierung:
$201.01B
Einnahmen:
$41.22B
Nettoeinkommen (Verlust:
$5.77B
KGV:
35.50
EPS:
3.29
Netto-Cashflow:
$6.49B
1W Leistung:
+3.34%
1M Leistung:
+2.24%
6M Leistung:
+14.47%
1J Leistung:
+1.83%
1-Tages-Spanne:
$114.14
$116.90
1-Wochen-Bereich:
$110.86
$116.90
52-Wochen-Spanne:
$99.71
$121.64
Abbott Laboratories Stock (ABT) Company Profile
Firmenname
Abbott Laboratories
Sektor
Branche
Telefon
(224) 667-6100
Adresse
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Vergleichen Sie ABT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-08 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-30 | Herabstufung | Edward Jones | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-21 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Bestätigt | Barclays | Overweight |
| 2023-04-20 | Bestätigt | Bernstein | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Raymond James | Outperform |
| 2023-04-20 | Bestätigt | UBS | Buy |
| 2023-04-20 | Bestätigt | Wolfe Research | Underperform |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-27 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-27 | Bestätigt | Morgan Stanley | Overweight |
| 2022-01-27 | Bestätigt | Raymond James | Outperform |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-27 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Neutral |
| 2021-01-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-06-01 | Herabstufung | Goldman | Neutral → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Neutral |
| 2020-01-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-02-07 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2018-11-30 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-01-30 | Bestätigt | Citigroup | Neutral |
| 2018-01-25 | Bestätigt | Stifel | Buy |
| 2018-01-25 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-10-19 | Bestätigt | Stifel | Buy |
Alle ansehen
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Abbott Laboratories set for stellar Q4 2024 earnings amid optimism for 2025 (NYSE:ABT) - Seeking Alpha
Abbott Laboratories (NYSE:ABT) Given "Outperform" Rating at Royal Bank of Canada - MarketBeat
Body Area Network Business Research Report 2024: Global Market to Reach $131 Billion by 2030, Fueled by Expansion of IoT-Enabled Wearables in Consumer and Medical - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Shares Bought by Atomi Financial Group Inc. - MarketBeat
Transform Wealth LLC Acquires 3,875 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Structural Heart Devices Market Set to Witness Significant Growth by 2024-2031 | Abbott Laboratories, - EIN News
Lmcg Investments LLC Sells 9,515 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Ballentine Partners LLC Has $4.93 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Saudi Arabia IVD Market Outlook & Company Analysis - GlobeNewswire
Antacid Medications Market Is Booming Worldwide 2025-2032 | - openPR
Short Interest in Abbott Laboratories (NYSE:ABT) Increases By 18.3% - MarketBeat
Abbott Stock Ahead of Q4 Earnings Results: Smart Buy or Risky Move? - Nasdaq
Abbott Laboratories (NYSE:ABT) Shares Purchased by LVW Advisors LLC - MarketBeat
MassMutual Private Wealth & Trust FSB Sells 3,245 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Week ahead: Trump inauguration, initial jobless claims in focus - Proactive Investors USA
Annex Advisory Services LLC Purchases 3,177 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Arkadios Wealth Advisors Sells 3,749 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Carotid Stent Market Overall Study Report 2025-2032 | Abbott Laboratories, B. Braun SE, Biotronik SE & Co KG - openPR
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas - AOL
Abbott Laboratories (NYSE:ABT) Shares Purchased by Financial & Tax Architects LLC - MarketBeat
HB Wealth Management LLC Purchases 14,259 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Verity & Verity LLC Increases Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Lummis Asset Management LP Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Integrated Investment Consultants LLC Acquires 11,475 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Folger Nolan Fleming Douglas Capital Management Inc. Sells 3,851 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Lifted by Brooklyn Investment Group - MarketBeat
Aaron Wealth Advisors LLC Has $1.47 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Looking to the Future: Why Abbott Laboratories is a Must-Watch Stock - Jomfruland.net
Jim Cramer on Abbott Laboratories (ABT): ‘I Think Abbott Will Win These Baby Formula Cases’ - Insider Monkey
9 Stocks on Jim Cramer’s Radar - Insider Monkey
5,660 Shares in Abbott Laboratories (NYSE:ABT) Bought by Sax Wealth Advisors LLC - MarketBeat
Merit Financial Group LLC Buys 7,316 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Hennion & Walsh Asset Management Inc. Has $1.45 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Trust Co. of Vermont Sells 9,600 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Biomarker Industry Market is Booming Worldwide | Abbott Laboratories, Roche Diagnostics - openPR
Relyea Zuckerberg Hanson LLC Purchases 14,960 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Householder Group Estate & Retirement Specialist LLC - MarketBeat
Avanza Fonder AB Invests $20.64 Million in Abbott Laboratories (NYSE:ABT) - MarketBeat
Tompkins Financial Corp Buys 2,410 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Chemistry Wealth Management LLC Makes New $267,000 Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Declining Stock and Decent Financials: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? - Yahoo Finance
Empirical Asset Management LLC Has $5.41 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Inspirion Wealth Advisors LLC - MarketBeat
Ritholtz Wealth Management Grows Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Carnegie Investment Counsel Increases Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Marker Testing Market May See a Big Move | Abbott Laboratories, Thermo Fisher Scientific - openPR
Abbott Laboratories (ABT) to Release Earnings on Wednesday - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott pushes toddler milks that can cause health issues: lawsuit - New York Post
Abbott Laboratories (NYSE:ABT) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
StrongBox Wealth LLC Raises Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Finanzdaten der Abbott Laboratories-Aktie (ABT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):